Subtotal ₹0.00
Vitamedix, a prominent name in the pharmaceutical industry, recently held a spectacular event to launch its latest range of general medicines. The occasion was graced by the celebrated Bengali film star and brand ambassador, Sudip Mukherjee, along with the directors of Vitamedix. The event drew significant attention from media and industry professionals, highlighting Vitamedix’s commitment to enhancing healthcare.
The presence of Sudip Mukherjee, renowned for his remarkable contributions to Bengali cinema, added a touch of glamour and credibility to the event. As Vitamedix’s brand ambassador, Mukherjee’s association underscores the brand’s dedication to quality and excellence. His participation not only attracted widespread media coverage but also emphasized the company’s connection to cultural icons and its dedication to improving health and wellness.
Vitamedix introduced an impressive lineup of general medicines, each designed to address common health concerns with innovative and effective solutions. The new products include:
HEPDINE SYRUP: Aimed at improving liver health and detoxification.
VITAFLAM-SP TABLETS: For relief from pain and inflammation.
VITZYME SYRUP: To aid digestion and improve overall gastrointestinal health.
VITZOLE-D CAPSULES: A combination of vitamins and minerals for overall well-being.
MONTE-LC TABLETS: To combat allergies and respiratory issues.
VITPAN-DSR CAPSULES: For the treatment of acid reflux and gastroesophageal reflux disease (GERD).
VIKORYL-LS SYRUP: A remedy for cold, cough, and flu symptoms.
VINAC-MR TABLETS: For pain relief and muscle relaxation.
VITLIV SYRUP: To support liver function and health.
POLYVITA-L SYRUP: A multivitamin syrup for boosting immunity and overall health.
The directors of Vitamedix shared their vision and the extensive research and development efforts behind these new products. They acknowledged the dedication of their R&D team and emphasized the company’s goal of making healthcare solutions more accessible and effective. They also hinted at more innovative products in the pipeline, reaffirming their commitment to leading the industry in pharmaceutical advancements.
